Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Lymphoid 1

Conditions

Substance-Related Disorders 1Pediatric Obesity 1Opioid-Related Disorders 1Lymphoma, Follicular 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Ultrasonic Waves × 1 year × Clear all
NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

NCT05050539 2026-02-23

Adaptive Implementation to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings

University of Arkansas

Phase NA Active not recruiting
1,850 enrolled
Other

Pediatric Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡